Cancer Research of Long Island — Great Neck, New York

Cancer Research of Long Island is a clinical research site located in Great Neck, New York, United States 11023.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer Research of Long Island has participated in 4 clinical trials.

Therapeutic areas: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Sponsors: Novartis, Astex Pharmaceuticals, Inc., Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Research of Long Island?

Cancer Research of Long Island has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Research of Long Island conducted?

Cancer Research of Long Island has 4 clinical trials on record. Their work covers Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Is Cancer Research of Long Island accredited by Crixeo Health?

Cancer Research of Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Research of Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.